HNRNPM and Ewing sarcoma: Remarkably, silencing of SRSF3 and HNRNPM, impacts on DHX9 expression as well as on Ewing sarcoma cell viability and proliferation, while it reduces survival of Ewing sarcoma cells to doxorubicin treatment.